Physician profile
Peter Shorten
NPI 1902223043
$8,369.55
in general payments reported to CMS, 2019-2025
10 companies · $1,214 in 2025
The $1,214 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2021: $452 · 2022: $5,300 · 2023: $335 · 2024: $264 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $866 · Food and Beverage: $458 · Gift: $442 · Entertainment: $46.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $866.03 |
| Food and Beverage | $457.59 |
| Gift | $442.14 |
| Entertainment | $46.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexus Spine, LLC | $6,106.92 | 2021-2024 | Presson |
| Alliance Medical | $950.28 | 2025 | |
| Synthes Gmbh | $804.83 | 2019 | |
| Arthrex, INC. | $204.95 | 2025 | |
| Spinal Elements, INC. | $169.27 | 2021 | |
| Cerapedics INC. | $68.95 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Mml US, INC. | $35.72 | 2025 | Reactiv8 |
| Smith+Nephew, INC. | $15.94 | 2023 | Renasys Go V2 Home, Pico 7 |
| Radius Health, INC. | $12.69 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$974,951.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Shorten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.